摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cephalotaxinamide

中文名称
——
中文别名
——
英文名称
cephalotaxinamide
英文别名
8-oxocephalotaxine;(2S,3S,6R)-3-hydroxy-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-9-one
cephalotaxinamide化学式
CAS
——
化学式
C18H19NO5
mdl
——
分子量
329.353
InChiKey
WLFMEQAKLOQAMK-KURKYZTESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    24
  • 可旋转键数:
    1
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    68.2
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    三尖杉碱sodium periodate 作用下, 以 甲醇 为溶剂, 反应 20.0h, 以29.9 mg的产率得到cephalotaxinamide
    参考文献:
    名称:
    高碘酸钠介导的Harringtonine衍生物及其对HL-60急性白血病细胞的抗增殖活性
    摘要:
    Harringtonine(HT)是从植物头孢属中分离的天然生物碱。它具有抗白血病的活性,已在临床上用于治疗急性白血病和淋巴瘤。高碘酸钠(NaIO 4)与HT反应生成5种HT衍生物,其中包括4种新化合物。它们对HL-60急性早幼粒细胞白血病细胞的抗增殖活性表明C-5'甲基的存在增强了抗增殖活性,因为HT衍生物(包括HT1(5'-de- O)的IC 50值-甲基harringtonine)(至少> 100μM)比HT(〜47 nM)高至少2000倍。此外,使用抗HT单克隆抗体(mAb 1D2)的间接竞争酶联免疫吸附测定(icELISA)显示,这些抗增殖活性与其细胞摄取有关。这些结果表明HT1在C-4'羧酸基团上的酯化可以增强HT的抗增殖活性。
    DOI:
    10.1021/acs.jnatprod.7b00541
点击查看最新优质反应信息

文献信息

  • A total synthesis of (.+-.)-cephalotaxinamide.
    作者:Shingo Yasuda、Youichi Yamamoto、Shuji Yoshida、Miyoji Hanaoka
    DOI:10.1248/cpb.36.4229
    日期:——
    (±)-Cephalotaxinamide (6) was synthesized from pyroglutamic acid via the pyrrolobenzazepine (4) through the Claisen rearrangement, the Wacker oxidation, aldol condensation, and hydroxylation with iodosobenzene.
    (±)-Cephalotaxinamide (6)是由焦谷氨酸通过吡咯并氮杂卓(4)经克莱森重排、瓦克氧化、醛醇缩合和碘苯羟基化反应合成的。
  • Total syntheses of (.+-.)-cephalotaxine and (.+-.)-8-oxocephalotaxine
    作者:Martin E. Kuehne、William G. Bornmann、William H. Parsons、Timothy D. Spitzer、J. F. Blount、J. Zubieta
    DOI:10.1021/jo00250a008
    日期:1988.7
  • CN116425760
    申请人:——
    公开号:——
    公开(公告)日:——
  • Sodium-Periodate-Mediated Harringtonine Derivatives and Their Antiproliferative Activity against HL-60 Acute Leukemia Cells
    作者:Seiichi Sakamoto、Tomofumi Miyamoto、Kazuteru Usui、Hiroyuki Tanaka、Satoshi Morimoto
    DOI:10.1021/acs.jnatprod.7b00541
    日期:2018.1.26
    antileukemic activity and has been clinically utilized for the treatment of acute leukemia and lymphoma. Sodium periodate (NaIO4) was reacted with HT to produce five HT derivatives including four novel compounds. Their antiproliferative activity against HL-60 acute promyelocytic leukemia cells revealed that the presence of the C-5′ methyl group enhances the antiproliferative activity because the IC50
    Harringtonine(HT)是从植物头孢属中分离的天然生物碱。它具有抗白血病的活性,已在临床上用于治疗急性白血病和淋巴瘤。高碘酸钠(NaIO 4)与HT反应生成5种HT衍生物,其中包括4种新化合物。它们对HL-60急性早幼粒细胞白血病细胞的抗增殖活性表明C-5'甲基的存在增强了抗增殖活性,因为HT衍生物(包括HT1(5'-de- O)的IC 50值-甲基harringtonine)(至少> 100μM)比HT(〜47 nM)高至少2000倍。此外,使用抗HT单克隆抗体(mAb 1D2)的间接竞争酶联免疫吸附测定(icELISA)显示,这些抗增殖活性与其细胞摄取有关。这些结果表明HT1在C-4'羧酸基团上的酯化可以增强HT的抗增殖活性。
查看更多

同类化合物

高三尖杉酯碱酰胺 高三尖杉酯碱 氧桥三尖杉碱 异三尖杉酯碱 双(去甲基)-脱氧三尖杉酯碱 去甲基三尖杉酮碱 去氧哈林通碱 乙酰三尖杉碱 三尖杉酯碱 三尖杉碱 4-羟基三尖杉碱 4'-去甲基高三尖杉酯碱 (1S,3aR)-1,5,6,8,9,14bbeta-六氢-2-甲氧基-4H-环戊并[a][1,3]二氧杂环戊并[4,5-H]吡咯并[2,1-b][3]苯并氮杂卓-1alpha,9alpha-二醇 (-)-脱水三尖杉酯碱 nordeoxyharringtonine cephalotaxine 4′-demethylharringtonine homoharringtonine α-N-oxide cephalotaxine α-N-oxide cephalotaxine α-N-oxide cephalotaxine β-N-oxide (2R,3R,4S,5S)-2,3-bis(tert-butyldiphenylsilyloxy)-cephalotaxan-8-one (2S,3R,5S,7S)-3-methyl-4,17,19-trioxa-11-azahexacyclo[12.7.0.02,7.03,5.07,11.016,20]henicosa-1(21),14,16(20)-triene (2S,6S)-3-methyl-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),3,13,15(19)-tetraene (1S)-2-methoxy-(3atC4,14bt)-1,5,6,8,9,14b-hexahydro-4H-1r,9c-epioxido-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepine 1-O-[(2R,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate 2,3,5,6,8,9-hexahydro-1-(pivaloyloxy)-4H-cyclopenta<1,3>dioxolo<4,5-h>pyrrolo<2,1-b><3>benzazepine Dimethyl 3-(trifluoromethylsulfonyloxy)-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),2,7,13,15(19)-pentaene-7,8-dicarboxylate Alkaloid D Epicephalotaxin Cephalotaxin a u. b (3aα,4aS*,15bβ,15cα)-(+/-)-3a,4,6,7,9,10,15b,15c-octahydro-2,2-dimethyl-5H-<1,3>dioxolo<4,5-h>-1,3-dioxolo<4,5>cyclopenta<1,2-a>pyrrolo<2,1-b><3>-benzazepine 4-Hydroxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),13,15(19)-trien-3-one (Ξ)-2-methyl-2-(2,2,2-trichloro-ethoxycarbonyloxy)-butyric acid (3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl ester (3aR)-2-methoxy-1t-(2,2,2-trichloro-ethoxycarbonyloxy)-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepine (S)-phenyl-(2,2,2-trichloro-ethoxycarbonyloxy)-acetic acid (3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl ester oxalic acid ethyl ester (3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl ester (3aR)-1t-benzyloxycarbonyloxy-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepine (S)-hydroxy-phenyl-acetic acid (3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl ester [(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] (2R)-2-[2-(furan-2-ylmethylamino)-2-oxoethyl]-2,6-dihydroxy-6-methylheptanoate (+/-)-3-dehydroxy-2-demethoxy-1,2-dihydro-2,8-dioxocephalotaxine epi-deoxyharringtonine hexa-2t,4t-dienoic acid (3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl ester Dehydrodeoxyhomoharringtonine [(2S,4S,6S)-12-methylsulfanyl-11-oxo-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),13,15(19)-trien-4-yl] acetate Omacetaxine mepesuccinate hydrochloride cephalotaxinamide (1R,2S,3aS,14bR)-1,2,3,5,6,8,9,14b-Octahydro-4H-cyclopenta<1,3>dioxolo<4,5-h>pyrrolo<2,1-b><3>benzazepine-1,2-diol methylfumaric acid 1-((3aR)-2-methoxy-(3arC4,14bc)-1,5,6,8,9,14b-hexahydro-4H-cyclopenta[b][1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepin-1t-yl) ester 4-methyl ester 11alpha-Hydroxycephalotaxine